Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report)'s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $26.06 and last traded at $25.57, with a volume of 88111 shares trading hands. The stock had previously closed at $24.58.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on the stock. Stifel Nicolaus assumed coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They set a "buy" rating and a $28.00 price objective on the stock. Piper Sandler initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set an "overweight" rating and a $27.00 price target for the company. Wells Fargo & Company started coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued an "overweight" rating and a $28.00 price target for the company. Bank of America began coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They set a "buy" rating and a $30.00 price objective on the stock. Finally, The Goldman Sachs Group initiated coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They issued a "neutral" rating and a $24.00 target price for the company. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $27.67.
View Our Latest Report on Kestra Medical Technologies
Kestra Medical Technologies Stock Down 2.1 %
About Kestra Medical Technologies
(
Get Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Featured Articles
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
